Please note that masks must still be worn within NYOH practices regardless of vaccination status.
Learn more about this and other COVID-19 related updates

About Us

Dr. Weissman on Keytruda

9/10/2014

New York Oncology Hematology’s Dr. Charles Weissman, an expert on melanoma, speaks with Newschannel 13 health reporter Benita Zahn about the groundbreaking FDA approval of anti-cancer drug Keytruda.

Jack Lewis, a patient of Dr. Weissman’s, who is currently participating in a clinical trial through New York Oncology Hematology for another melanoma treatment, shares his story and why he believes the clinical trial treatment is helping him live a longer life.

With the largest, most comprehensive clinical trial program in the region, New York Oncology Hematology and our patients have played a pivotal role in FDA approval of 38 anti-cancer drugs over the past 20 years.